Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 12/20 | 0.61 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7056044 | 0.87 | MTNR1A (0.61) | MTNR1AMTNR1BTRPV1HTR2AHTR2C | |
| SCHEMBL9671722 | 0.76 | MTNR1A (1.00) | MTNR1AMTNR1BTRPV1HTR2AHTR2C | |
| SCHEMBL9671286 | 0.76 | MTNR1A (1.00) | MTNR1AMTNR1BTRPV1HTR2AHTR2C | |
| SCHEMBL7055939 | 0.76 | MTNR1A (1.00) | MTNR1AMTNR1BTRPV1HTR2AHTR2C | |
| SCHEMBL7057928 | 0.74 | MTNR1A (0.42) | MTNR1AMTNR1BTRPV1HTR2C | |
| SCHEMBL7055753 | 0.74 | MTNR1A (0.51) | MTNR1AMTNR1BTRPV1HTR2B | |
| SCHEMBL7051405 | 0.74 | MTNR1A (0.78) | MTNR1AMTNR1BTRPV1HTR2B | |
| SCHEMBL7057717 | 0.72 | MTNR1A (0.53) | MTNR1AMTNR1BTRPV1 | |
| SCHEMBL7057489 | 0.71 | MTNR1A (0.49) | MTNR1AMTNR1BTRPV1HTR2CTHRA | |
| SCHEMBL7057705 | 0.71 | MTNR1A (0.60) | MTNR1AMTNR1BTRPV1HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0656209-B1 | Melatonin derivatives for use in treating desynchronization disorders | LILLY CO ELI (US) | 2003-05-07 | — | — | EP | disclosed |
| CN-1100533-C | Melatonin derivatives for use in terating desynchronization disorders | LILLY CO ELI (US) | 2003-02-05 | — | — | CN | disclosed |
| CN-1092958-C | Melatonin derivatives for use in treating sleep disorders | LILLY CO ELI (US) | 2002-10-23 | — | — | CN | disclosed |
| EP-0655243-B1 | Melatonin derivatives for use in treating sleep disorders | LILLY CO ELI (US) | 2002-08-21 | — | — | EP | disclosed |
| US-6180657-B1 | SLEEP DISORDERS | ELI LILLY AND COMPANY | 2001-01-30 | — | — | US | disclosed |
| CN-1191484-A | Melatonin agonists for treating benign prostatic hyperplasia | LILLY CO ELI (US) | 1998-08-26 | — | — | CN | disclosed |
| US-5770610-A | ADMINISTERING R-(+)-N-(2-METHYL-2-(5-METHOXY-6-CHLOROINDOL-3-YL)ETHYL) ACETAMIDE | ELI LILLY AND COMPANY (US) | 1998-06-23 | — | — | US | disclosed |
| US-5654325-A | Melatonin derivatives for use in treating sleep disorders | ELI LILLY AND COMPANY (US) | 1997-08-05 | — | — | US | disclosed |
| EP-0748627-A2 | Melatonin agonists for use in the treatment of benign prostatic hyperplasia | ELI LILLY AND COMPANY (US) | 1996-12-18 | — | — | EP | disclosed |
| CN-1107701-A | Melatonin derivatives for use in treating sleep disorders | LILLY CO ELI (US) | 1995-09-06 | — | — | CN | disclosed |
| CN-1107700-A | Melatonin derivatives for use in terating desynchronization disorders | LILLY CO ELI (US) | 1995-09-06 | — | — | CN | disclosed |
| EP-0656209-A2 | Melatonin derivatives for use in treating desynchronization disorders | ELI LILLY AND COMPANY (US) | 1995-06-07 | — | — | EP | disclosed |
| EP-0655243-A2 | Melatonin derivatives for use in treating sleep disorders | ELI LILLY AND COMPANY (US) | 1995-05-31 | — | — | EP | disclosed |
| US-4997845-A | β-alkylmelatonins as ovulation inhibitors | ELI LILLY AND COMPANY (US) | 1991-03-05 | — | — | US | disclosed |